Novel ultra-long-acting biologic depemokimab reduced nasal polyps in chronic rhinosinusitis, two parallel phase III trials ...

Phase 3 trials showed significant improvements in nasal polyp size and obstruction. Every week, our Whisper Index uncovers five overlooked stocks with big breakout potential. Get the latest picks ...

which found that treatment with Fasenra achieved a statistically significant improvement in the endoscopic total nasal polyp score and nasal blockage score compared to placebo, in patients with ...

The monoclonal antibody against thymic stromal lymphopoietin (TSLP) improved total nasal-polyp score by a mean -2.07 points (95% CI −2.39 to −1.74) more than placebo on a 0-4 point scale at 52 ...

The coprimary end points were the changes from baseline in the total nasal-polyp score (range, 0 to 4 [for each nostril]; higher scores indicate greater severity) and the mean nasal-congestion ...